Corporate Focus

Corporate Focus

With more than 250,000 units in the field, Defibtech has drawn accolades for its commitment to save lives by producing the best AEDs medical technology can offer. Defibtech is an industry leader that constantly drives research and innovation to the next level of excellence.

Defibtech was founded in 1999 by Dr. Glenn W. Laub, cardiothoracic surgeon and Professor and Chairman of Cardiac Surgery at Drexel College of Medicine and Clinical Section Chief at Hahnemann University Hospital in Philadelphia, PA, and his longtime friend and fellow Yale graduate, Gintaras Vaisnys, an engineer who has founded several technology companies.

Their vision: to combine their experience and build a company to create and manufacture one of the world’s best AEDs. To that end, the company’s focus was and is exclusively AEDs.

Introduced in 2003, the Defibtech AED revolutionized the marketplace. It offered the highest levels of quality and reliability in a full-featured device at half the price of its competitors.

Defibtech defibrillators are manufactured in the United States in state-of-the-art certified facilities.

Among the many honors, prizes, and distinctions garnered over the years, was the selection of Defibtech AEDs to protect athletes and spectators at the Winter Olympic Games in Torino, Italy.